On September 5, 2019 Merck (NYSE: MRK), known as MSD outside the United States and Canada, reported that Kenneth C. Frazier, chairman and chief executive officer, and Dr. Roger M. Perlmutter, president, Merck Research Laboratories, are scheduled to present during a fireside chat at the Morgan Stanley 17th Annual Global Healthcare Conference in New York on Sept. 9, 2019 at 10:30 a.m. EDT (Press release, Merck & Co, SEP 5, 2019, View Source [SID1234539299]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at https://cc.talkpoint.com/morg007/090919b_js/?entity=73_1XEFBTH.